Global Infantile Spasms Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Description

An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.

According to our (Global Info Research) latest study, the global Infantile Spasms Therapeutics market size was valued at USD 146.1 million in 2022 and is forecast to a readjusted size of USD 185.2 million by 2029 with a CAGR of 3.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Infantile Spasms Therapeutics key players include Mallinckrodt, H. Lundbeck, etc. Global top two manufacturers hold a share over 60%.

In terms of product, Oral is the largest segment, with a share obout 55%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.

This report is a detailed and comprehensive analysis for global Infantile Spasms Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Infantile Spasms Therapeutics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Infantile Spasms Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Infantile Spasms Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Infantile Spasms Therapeutics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Infantile Spasms Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Infantile Spasms Therapeutics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mallinckrodt, H. Lundbeck, Insys Therapeutics, Orphelia Pharma and Valerion Therapeutics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Infantile Spasms Therapeutics market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Oral
    Injection

Market segment by Application
    Hospital
    Clinic
    Other

Market segment by players, this report covers
    Mallinckrodt
    H. Lundbeck
    Insys Therapeutics
    Orphelia Pharma
    Valerion Therapeutics
    Catalyst Pharmaceuticals
    Anavex Life Sciences
    Retrophin
    GW Pharmaceuticals

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Infantile Spasms Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Infantile Spasms Therapeutics, with revenue, gross margin and global market share of Infantile Spasms Therapeutics from 2018 to 2023.
Chapter 3, the Infantile Spasms Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Infantile Spasms Therapeutics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Infantile Spasms Therapeutics.
Chapter 13, to describe Infantile Spasms Therapeutics research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Infantile Spasms Therapeutics
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Infantile Spasms Therapeutics by Type
        1.3.1 Overview: Global Infantile Spasms Therapeutics Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Infantile Spasms Therapeutics Consumption Value Market Share by Type in 2022
        1.3.3 Oral
        1.3.4 Injection
    1.4 Global Infantile Spasms Therapeutics Market by Application
        1.4.1 Overview: Global Infantile Spasms Therapeutics Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital
        1.4.3 Clinic
        1.4.4 Other
    1.5 Global Infantile Spasms Therapeutics Market Size & Forecast
    1.6 Global Infantile Spasms Therapeutics Market Size and Forecast by Region
        1.6.1 Global Infantile Spasms Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Infantile Spasms Therapeutics Market Size by Region, (2018-2029)
        1.6.3 North America Infantile Spasms Therapeutics Market Size and Prospect (2018-2029)
        1.6.4 Europe Infantile Spasms Therapeutics Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Infantile Spasms Therapeutics Market Size and Prospect (2018-2029)
        1.6.6 South America Infantile Spasms Therapeutics Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Infantile Spasms Therapeutics Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Mallinckrodt
        2.1.1 Mallinckrodt Details
        2.1.2 Mallinckrodt Major Business
        2.1.3 Mallinckrodt Infantile Spasms Therapeutics Product and Solutions
        2.1.4 Mallinckrodt Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Mallinckrodt Recent Developments and Future Plans
    2.2 H. Lundbeck
        2.2.1 H. Lundbeck Details
        2.2.2 H. Lundbeck Major Business
        2.2.3 H. Lundbeck Infantile Spasms Therapeutics Product and Solutions
        2.2.4 H. Lundbeck Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 H. Lundbeck Recent Developments and Future Plans
    2.3 Insys Therapeutics
        2.3.1 Insys Therapeutics Details
        2.3.2 Insys Therapeutics Major Business
        2.3.3 Insys Therapeutics Infantile Spasms Therapeutics Product and Solutions
        2.3.4 Insys Therapeutics Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Insys Therapeutics Recent Developments and Future Plans
    2.4 Orphelia Pharma
        2.4.1 Orphelia Pharma Details
        2.4.2 Orphelia Pharma Major Business
        2.4.3 Orphelia Pharma Infantile Spasms Therapeutics Product and Solutions
        2.4.4 Orphelia Pharma Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Orphelia Pharma Recent Developments and Future Plans
    2.5 Valerion Therapeutics
        2.5.1 Valerion Therapeutics Details
        2.5.2 Valerion Therapeutics Major Business
        2.5.3 Valerion Therapeutics Infantile Spasms Therapeutics Product and Solutions
        2.5.4 Valerion Therapeutics Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Valerion Therapeutics Recent Developments and Future Plans
    2.6 Catalyst Pharmaceuticals
        2.6.1 Catalyst Pharmaceuticals Details
        2.6.2 Catalyst Pharmaceuticals Major Business
        2.6.3 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Product and Solutions
        2.6.4 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Catalyst Pharmaceuticals Recent Developments and Future Plans
    2.7 Anavex Life Sciences
        2.7.1 Anavex Life Sciences Details
        2.7.2 Anavex Life Sciences Major Business
        2.7.3 Anavex Life Sciences Infantile Spasms Therapeutics Product and Solutions
        2.7.4 Anavex Life Sciences Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Anavex Life Sciences Recent Developments and Future Plans
    2.8 Retrophin
        2.8.1 Retrophin Details
        2.8.2 Retrophin Major Business
        2.8.3 Retrophin Infantile Spasms Therapeutics Product and Solutions
        2.8.4 Retrophin Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Retrophin Recent Developments and Future Plans
    2.9 GW Pharmaceuticals
        2.9.1 GW Pharmaceuticals Details
        2.9.2 GW Pharmaceuticals Major Business
        2.9.3 GW Pharmaceuticals Infantile Spasms Therapeutics Product and Solutions
        2.9.4 GW Pharmaceuticals Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 GW Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Infantile Spasms Therapeutics Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Infantile Spasms Therapeutics by Company Revenue
        3.2.2 Top 3 Infantile Spasms Therapeutics Players Market Share in 2022
        3.2.3 Top 6 Infantile Spasms Therapeutics Players Market Share in 2022
    3.3 Infantile Spasms Therapeutics Market: Overall Company Footprint Analysis
        3.3.1 Infantile Spasms Therapeutics Market: Region Footprint
        3.3.2 Infantile Spasms Therapeutics Market: Company Product Type Footprint
        3.3.3 Infantile Spasms Therapeutics Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Infantile Spasms Therapeutics Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Infantile Spasms Therapeutics Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Infantile Spasms Therapeutics Consumption Value Market Share by Application (2018-2023)
    5.2 Global Infantile Spasms Therapeutics Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Infantile Spasms Therapeutics Consumption Value by Type (2018-2029)
    6.2 North America Infantile Spasms Therapeutics Consumption Value by Application (2018-2029)
    6.3 North America Infantile Spasms Therapeutics Market Size by Country
        6.3.1 North America Infantile Spasms Therapeutics Consumption Value by Country (2018-2029)
        6.3.2 United States Infantile Spasms Therapeutics Market Size and Forecast (2018-2029)
        6.3.3 Canada Infantile Spasms Therapeutics Market Size and Forecast (2018-2029)
        6.3.4 Mexico Infantile Spasms Therapeutics Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Infantile Spasms Therapeutics Consumption Value by Type (2018-2029)
    7.2 Europe Infantile Spasms Therapeutics Consumption Value by Application (2018-2029)
    7.3 Europe Infantile Spasms Therapeutics Market Size by Country
        7.3.1 Europe Infantile Spasms Therapeutics Consumption Value by Country (2018-2029)
        7.3.2 Germany Infantile Spasms Therapeutics Market Size and Forecast (2018-2029)
        7.3.3 France Infantile Spasms Therapeutics Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Infantile Spasms Therapeutics Market Size and Forecast (2018-2029)
        7.3.5 Russia Infantile Spasms Therapeutics Market Size and Forecast (2018-2029)
        7.3.6 Italy Infantile Spasms Therapeutics Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Infantile Spasms Therapeutics Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Infantile Spasms Therapeutics Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Infantile Spasms Therapeutics Market Size by Region
        8.3.1 Asia-Pacific Infantile Spasms Therapeutics Consumption Value by Region (2018-2029)
        8.3.2 China Infantile Spasms Therapeutics Market Size and Forecast (2018-2029)
        8.3.3 Japan Infantile Spasms Therapeutics Market Size and Forecast (2018-2029)
        8.3.4 South Korea Infantile Spasms Therapeutics Market Size and Forecast (2018-2029)
        8.3.5 India Infantile Spasms Therapeutics Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Infantile Spasms Therapeutics Market Size and Forecast (2018-2029)
        8.3.7 Australia Infantile Spasms Therapeutics Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Infantile Spasms Therapeutics Consumption Value by Type (2018-2029)
    9.2 South America Infantile Spasms Therapeutics Consumption Value by Application (2018-2029)
    9.3 South America Infantile Spasms Therapeutics Market Size by Country
        9.3.1 South America Infantile Spasms Therapeutics Consumption Value by Country (2018-2029)
        9.3.2 Brazil Infantile Spasms Therapeutics Market Size and Forecast (2018-2029)
        9.3.3 Argentina Infantile Spasms Therapeutics Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Infantile Spasms Therapeutics Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Infantile Spasms Therapeutics Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Infantile Spasms Therapeutics Market Size by Country
        10.3.1 Middle East & Africa Infantile Spasms Therapeutics Consumption Value by Country (2018-2029)
        10.3.2 Turkey Infantile Spasms Therapeutics Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Infantile Spasms Therapeutics Market Size and Forecast (2018-2029)
        10.3.4 UAE Infantile Spasms Therapeutics Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Infantile Spasms Therapeutics Market Drivers
    11.2 Infantile Spasms Therapeutics Market Restraints
    11.3 Infantile Spasms Therapeutics Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Infantile Spasms Therapeutics Industry Chain
    12.2 Infantile Spasms Therapeutics Upstream Analysis
    12.3 Infantile Spasms Therapeutics Midstream Analysis
    12.4 Infantile Spasms Therapeutics Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Infantile Spasms Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Infantile Spasms Therapeutics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Infantile Spasms Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Infantile Spasms Therapeutics Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Mallinckrodt Company Information, Head Office, and Major Competitors
    Table 6. Mallinckrodt Major Business
    Table 7. Mallinckrodt Infantile Spasms Therapeutics Product and Solutions
    Table 8. Mallinckrodt Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Mallinckrodt Recent Developments and Future Plans
    Table 10. H. Lundbeck Company Information, Head Office, and Major Competitors
    Table 11. H. Lundbeck Major Business
    Table 12. H. Lundbeck Infantile Spasms Therapeutics Product and Solutions
    Table 13. H. Lundbeck Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. H. Lundbeck Recent Developments and Future Plans
    Table 15. Insys Therapeutics Company Information, Head Office, and Major Competitors
    Table 16. Insys Therapeutics Major Business
    Table 17. Insys Therapeutics Infantile Spasms Therapeutics Product and Solutions
    Table 18. Insys Therapeutics Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Insys Therapeutics Recent Developments and Future Plans
    Table 20. Orphelia Pharma Company Information, Head Office, and Major Competitors
    Table 21. Orphelia Pharma Major Business
    Table 22. Orphelia Pharma Infantile Spasms Therapeutics Product and Solutions
    Table 23. Orphelia Pharma Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Orphelia Pharma Recent Developments and Future Plans
    Table 25. Valerion Therapeutics Company Information, Head Office, and Major Competitors
    Table 26. Valerion Therapeutics Major Business
    Table 27. Valerion Therapeutics Infantile Spasms Therapeutics Product and Solutions
    Table 28. Valerion Therapeutics Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Valerion Therapeutics Recent Developments and Future Plans
    Table 30. Catalyst Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 31. Catalyst Pharmaceuticals Major Business
    Table 32. Catalyst Pharmaceuticals Infantile Spasms Therapeutics Product and Solutions
    Table 33. Catalyst Pharmaceuticals Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Catalyst Pharmaceuticals Recent Developments and Future Plans
    Table 35. Anavex Life Sciences Company Information, Head Office, and Major Competitors
    Table 36. Anavex Life Sciences Major Business
    Table 37. Anavex Life Sciences Infantile Spasms Therapeutics Product and Solutions
    Table 38. Anavex Life Sciences Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Anavex Life Sciences Recent Developments and Future Plans
    Table 40. Retrophin Company Information, Head Office, and Major Competitors
    Table 41. Retrophin Major Business
    Table 42. Retrophin Infantile Spasms Therapeutics Product and Solutions
    Table 43. Retrophin Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Retrophin Recent Developments and Future Plans
    Table 45. GW Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 46. GW Pharmaceuticals Major Business
    Table 47. GW Pharmaceuticals Infantile Spasms Therapeutics Product and Solutions
    Table 48. GW Pharmaceuticals Infantile Spasms Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. GW Pharmaceuticals Recent Developments and Future Plans
    Table 50. Global Infantile Spasms Therapeutics Revenue (USD Million) by Players (2018-2023)
    Table 51. Global Infantile Spasms Therapeutics Revenue Share by Players (2018-2023)
    Table 52. Breakdown of Infantile Spasms Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 53. Market Position of Players in Infantile Spasms Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 54. Head Office of Key Infantile Spasms Therapeutics Players
    Table 55. Infantile Spasms Therapeutics Market: Company Product Type Footprint
    Table 56. Infantile Spasms Therapeutics Market: Company Product Application Footprint
    Table 57. Infantile Spasms Therapeutics New Market Entrants and Barriers to Market Entry
    Table 58. Infantile Spasms Therapeutics Mergers, Acquisition, Agreements, and Collaborations
    Table 59. Global Infantile Spasms Therapeutics Consumption Value (USD Million) by Type (2018-2023)
    Table 60. Global Infantile Spasms Therapeutics Consumption Value Share by Type (2018-2023)
    Table 61. Global Infantile Spasms Therapeutics Consumption Value Forecast by Type (2024-2029)
    Table 62. Global Infantile Spasms Therapeutics Consumption Value by Application (2018-2023)
    Table 63. Global Infantile Spasms Therapeutics Consumption Value Forecast by Application (2024-2029)
    Table 64. North America Infantile Spasms Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
    Table 65. North America Infantile Spasms Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
    Table 66. North America Infantile Spasms Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
    Table 67. North America Infantile Spasms Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
    Table 68. North America Infantile Spasms Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
    Table 69. North America Infantile Spasms Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
    Table 70. Europe Infantile Spasms Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
    Table 71. Europe Infantile Spasms Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
    Table 72. Europe Infantile Spasms Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
    Table 73. Europe Infantile Spasms Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
    Table 74. Europe Infantile Spasms Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
    Table 75. Europe Infantile Spasms Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
    Table 76. Asia-Pacific Infantile Spasms Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
    Table 77. Asia-Pacific Infantile Spasms Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
    Table 78. Asia-Pacific Infantile Spasms Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
    Table 79. Asia-Pacific Infantile Spasms Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
    Table 80. Asia-Pacific Infantile Spasms Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
    Table 81. Asia-Pacific Infantile Spasms Therapeutics Consumption Value by Region (2024-2029) & (USD Million)
    Table 82. South America Infantile Spasms Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
    Table 83. South America Infantile Spasms Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
    Table 84. South America Infantile Spasms Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
    Table 85. South America Infantile Spasms Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
    Table 86. South America Infantile Spasms Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
    Table 87. South America Infantile Spasms Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
    Table 88. Middle East & Africa Infantile Spasms Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
    Table 89. Middle East & Africa Infantile Spasms Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
    Table 90. Middle East & Africa Infantile Spasms Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
    Table 91. Middle East & Africa Infantile Spasms Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
    Table 92. Middle East & Africa Infantile Spasms Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
    Table 93. Middle East & Africa Infantile Spasms Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
    Table 94. Infantile Spasms Therapeutics Raw Material
    Table 95. Key Suppliers of Infantile Spasms Therapeutics Raw Materials
List of Figures
    Figure 1. Infantile Spasms Therapeutics Picture
    Figure 2. Global Infantile Spasms Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Infantile Spasms Therapeutics Consumption Value Market Share by Type in 2022
    Figure 4. Oral
    Figure 5. Injection
    Figure 6. Global Infantile Spasms Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 7. Infantile Spasms Therapeutics Consumption Value Market Share by Application in 2022
    Figure 8. Hospital Picture
    Figure 9. Clinic Picture
    Figure 10. Other Picture
    Figure 11. Global Infantile Spasms Therapeutics Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Infantile Spasms Therapeutics Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Market Infantile Spasms Therapeutics Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 14. Global Infantile Spasms Therapeutics Consumption Value Market Share by Region (2018-2029)
    Figure 15. Global Infantile Spasms Therapeutics Consumption Value Market Share by Region in 2022
    Figure 16. North America Infantile Spasms Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 17. Europe Infantile Spasms Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 18. Asia-Pacific Infantile Spasms Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 19. South America Infantile Spasms Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 20. Middle East and Africa Infantile Spasms Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 21. Global Infantile Spasms Therapeutics Revenue Share by Players in 2022
    Figure 22. Infantile Spasms Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 23. Global Top 3 Players Infantile Spasms Therapeutics Market Share in 2022
    Figure 24. Global Top 6 Players Infantile Spasms Therapeutics Market Share in 2022
    Figure 25. Global Infantile Spasms Therapeutics Consumption Value Share by Type (2018-2023)
    Figure 26. Global Infantile Spasms Therapeutics Market Share Forecast by Type (2024-2029)
    Figure 27. Global Infantile Spasms Therapeutics Consumption Value Share by Application (2018-2023)
    Figure 28. Global Infantile Spasms Therapeutics Market Share Forecast by Application (2024-2029)
    Figure 29. North America Infantile Spasms Therapeutics Consumption Value Market Share by Type (2018-2029)
    Figure 30. North America Infantile Spasms Therapeutics Consumption Value Market Share by Application (2018-2029)
    Figure 31. North America Infantile Spasms Therapeutics Consumption Value Market Share by Country (2018-2029)
    Figure 32. United States Infantile Spasms Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 33. Canada Infantile Spasms Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 34. Mexico Infantile Spasms Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 35. Europe Infantile Spasms Therapeutics Consumption Value Market Share by Type (2018-2029)
    Figure 36. Europe Infantile Spasms Therapeutics Consumption Value Market Share by Application (2018-2029)
    Figure 37. Europe Infantile Spasms Therapeutics Consumption Value Market Share by Country (2018-2029)
    Figure 38. Germany Infantile Spasms Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 39. France Infantile Spasms Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 40. United Kingdom Infantile Spasms Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 41. Russia Infantile Spasms Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 42. Italy Infantile Spasms Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 43. Asia-Pacific Infantile Spasms Therapeutics Consumption Value Market Share by Type (2018-2029)
    Figure 44. Asia-Pacific Infantile Spasms Therapeutics Consumption Value Market Share by Application (2018-2029)
    Figure 45. Asia-Pacific Infantile Spasms Therapeutics Consumption Value Market Share by Region (2018-2029)
    Figure 46. China Infantile Spasms Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 47. Japan Infantile Spasms Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 48. South Korea Infantile Spasms Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 49. India Infantile Spasms Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 50. Southeast Asia Infantile Spasms Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 51. Australia Infantile Spasms Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 52. South America Infantile Spasms Therapeutics Consumption Value Market Share by Type (2018-2029)
    Figure 53. South America Infantile Spasms Therapeutics Consumption Value Market Share by Application (2018-2029)
    Figure 54. South America Infantile Spasms Therapeutics Consumption Value Market Share by Country (2018-2029)
    Figure 55. Brazil Infantile Spasms Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 56. Argentina Infantile Spasms Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 57. Middle East and Africa Infantile Spasms Therapeutics Consumption Value Market Share by Type (2018-2029)
    Figure 58. Middle East and Africa Infantile Spasms Therapeutics Consumption Value Market Share by Application (2018-2029)
    Figure 59. Middle East and Africa Infantile Spasms Therapeutics Consumption Value Market Share by Country (2018-2029)
    Figure 60. Turkey Infantile Spasms Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 61. Saudi Arabia Infantile Spasms Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 62. UAE Infantile Spasms Therapeutics Consumption Value (2018-2029) & (USD Million)
    Figure 63. Infantile Spasms Therapeutics Market Drivers
    Figure 64. Infantile Spasms Therapeutics Market Restraints
    Figure 65. Infantile Spasms Therapeutics Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of Infantile Spasms Therapeutics in 2022
    Figure 68. Manufacturing Process Analysis of Infantile Spasms Therapeutics
    Figure 69. Infantile Spasms Therapeutics Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source